Ooh, now of course our visiting down-rampers will mock the sample size of 320, knowing better than the research statistician of course, but for CYP shareholders, timelines just got favourably revised.
End of November 2023 recruitment and top line results presumably brought forward half a year or so.
Significant news if you are a CYP holder or prospective holder.
Ann: Phase 3 SCUlpTOR Osteoarthritis Clinical Trial Progress, page-2
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
32.0¢ |
Change
-0.015(4.48%) |
Mkt cap ! $57.48M | |||
| Open | High | Low | Value | Volume |
| 34.0¢ | 34.0¢ | 31.0¢ | $167.6K | 522.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 8217 | 31.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.5¢ | 5000 | 1 |
View Market Depth
| Last trade - 15.59pm 03/06/2024 (20 minute delay) ? |
|
|||||
|
Last
31.5¢ |
Change
-0.015 ( 4.55 %) |
||||
| Open | High | Low | Volume | ||
| 33.5¢ | 33.5¢ | 30.0¢ | 100689 | ||
| Last updated 14.55pm 03/06/2024 ? | |||||
| CYP (ASX) Chart |